Article
Efficacy and Safety of a COVID-19 Inactivated Vaccine in Healthcare Professionals in Brazil: The PROFISCOV Study
2021-04-14
Abstract excerpt
Background: Vaccines are urgently needed to tackle the unprecedented morbidity and mortality of COVID-19. Administration of inactivated viruses are the common and mature platform of developing new vaccines. CoronaVac is an inactivated vaccine that has undergone preclinical tests and phase I/II clinical trials.<br><br>Methods: We conducted a randomised, double-blind, placebo-controlled phase 3 clinical trial with C...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d6ca78c3-f55c-5f15-8871-b85693ca86f7
- DOI
- 10.2139/ssrn.3822780
